Literature DB >> 10837709

Cyclodextrins in ophthalmic drug delivery.

.   

Abstract

Most ocular diseases are treated by topical drug application in the form of aqueous eye drop solutions. Recent studies have shown that cyclodextrins are useful additives in ophthalmic formulations for increasing the aqueous solubility, aqueous stability and bioavailability of ophthalmic drugs, and to decrease drug irritation. However, these studies have also shown that there are some basic differences between ophthalmic administration of cyclodextrins and administration of cyclodextrins via other routes. These differences have induced some limitations in the ophthalmic application of these most recently developed pharmaceutical excipients. The objective of this review is to summarize recent findings and applications of various cyclodextrins in ophthalmic drug delivery. Their mechanism of action in aqueous eye drop formulations is also discussed. Finally, the formulation of a couple of cyclodextrin containing eye drop solutions is described.

Entities:  

Year:  1999        PMID: 10837709     DOI: 10.1016/s0169-409x(98)00055-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  33 in total

1.  Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.

Authors:  Goutham R Adelli; Tushar Hingorani; Nagendra Punyamurthula; Sai Prachetan Balguri; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2015-02-26       Impact factor: 5.571

Review 2.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

3.  Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.

Authors:  F Ahsan; J J Arnold; E Meezan; D J Pillion
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

4.  Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation.

Authors:  K Matti Saari; Laura Nelimarkka; Virpi Ahola; Thorsteinn Loftsson; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-11       Impact factor: 3.117

5.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.

Authors:  Sophie Laurent; Morteza Mahmoudi
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

6.  NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS.

Authors:  Mingnan Chen; Jonathan R McDaniel; J Andrew Mackay; Ashutosh Chilkoti
Journal:  Technol Innov       Date:  2011-01-01

7.  Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.

Authors:  Maria Letizia Manca; Marco Zaru; Guido Ennas; Donatella Valenti; Chiara Sinico; Giuseppe Loy; Anna Maria Fadda
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

Review 8.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

9.  Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  Pharm Res       Date:  2008-09-23       Impact factor: 4.200

Review 10.  Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective.

Authors:  Jianxiang Zhang; Peter X Ma
Journal:  Adv Drug Deliv Rev       Date:  2013-05-11       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.